OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
IBCH56

Indo Borax and Chemicals Ltd

Commodity ChemicalsVerified

Indo Borax and Chemicals Ltd maintains a strong liquidity position, with a current ratio of 8.76, indicating ample short-term assets to cover liabilities. The company has no long-term debt and a debt-to-equity ratio of 0.0, suggesting a conservative capital structure. However, its operating cash flow is negative at -INR 719.9 million, which may raise concerns about its ability to fund operations without external financing. Profitability metrics show a return on equity (ROE) of 12.67% and a return on assets (ROA) of 11.92%, both exceeding the typical thresholds for the Commodity Chemicals industry. The company’s gross profit margin is 47.4%, and its operating margin is 26.7%, indicating strong cost control and pricing power relative to industry norms. The company’s revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional demand fluctuations and regulatory changes in India. Outlook data indicates a projected revenue growth of 12.3% in the current fiscal year and 8.1% in the next fiscal year, driven by increased demand for lithium hydroxide in the battery sector. Historical revenue growth has averaged 9.5% annually over the past five years, suggesting a stable but moderate growth trajectory. Risk factors include a medium liquidity risk due to negative net cash and a potential dilution risk if the company issues additional shares to fund operations. The company has not disclosed any recent equity offerings or dilution events, but its negative operating cash flow may necessitate future financing. Recent filings and transcripts do not disclose any material events or strategic shifts. The company’s 10-K filing highlights ongoing investments in production capacity and cost optimization initiatives.

30-day price · IBCH+21.93 (+9.0%)
Low$240.31High$294.00Close$266.50As of12 May, 00:00 UTC
Profile
CompanyIndo Borax and Chemicals Ltd
TickerIBCH.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Indo Borax and Chemicals Ltd produces and sells boron and lithium products, including boric acid, borax decahydrate, and lithium hydroxide monohydrate, used in metallurgy, pharmaceuticals, and ceramics.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence.

Indo Borax and Chemicals Ltd maintains a strong liquidity position, with a current ratio of 8.76, indicating ample short-term assets to cover liabilities. The company has no long-term debt and a debt-to-equity ratio of 0.0, suggesting a conservative capital structure. However, its operating cash flow is negative at -INR 719.9 million, which may raise concerns about its ability to fund operations without external financing. Profitability metrics show a return on equity (ROE) of 12.67% and a return on assets (ROA) of 11.92%, both exceeding the typical thresholds for the Commodity Chemicals industry. The company’s gross profit margin is 47.4%, and its operating margin is 26.7%, indicating strong cost control and pricing power relative to industry norms. The company’s revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional demand fluctuations and regulatory changes in India. Outlook data indicates a projected revenue growth of 12.3% in the current fiscal year and 8.1% in the next fiscal year, driven by increased demand for lithium hydroxide in the battery sector. Historical revenue growth has averaged 9.5% annually over the past five years, suggesting a stable but moderate growth trajectory. Risk factors include a medium liquidity risk due to negative net cash and a potential dilution risk if the company issues additional shares to fund operations. The company has not disclosed any recent equity offerings or dilution events, but its negative operating cash flow may necessitate future financing. Recent filings and transcripts do not disclose any material events or strategic shifts. The company’s 10-K filing highlights ongoing investments in production capacity and cost optimization initiatives.
Key takeaways
  • Strong liquidity and no long-term debt support financial stability.
  • High ROE and ROA indicate efficient asset and equity utilization.
  • Revenue concentration in a single segment and geographic market increases risk.
  • Moderate revenue growth is expected, driven by lithium demand.
  • Negative operating cash flow may require external financing, raising dilution risk.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.75B
Gross profit$831.0M
Operating income$468.0M
Net income$425.1M
R&D
SG&A
D&A
SBC
Operating cash flow-$719.9M
CapEx-$67.3M
Free cash flow$352.1M
Total assets$3.57B
Total liabilities$212.6M
Total equity$3.35B
Cash & equivalents
Long-term debt$326.0k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.35B
Net cash-$326.0k
Current ratio8.8
Debt/Equity0.0
ROA11.9%
ROE12.7%
Cash conversion-1.7%
CapEx/Revenue-3.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricIBCHActivity
Op margin26.7%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin24.3%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin47.4%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity0.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:47 UTC#c21d05ec
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:49 UTCJob: c0bee20e